BERKELEY, Calif., and VANCOUVER, British Columbia, Oct. 06, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (" BriaCell " or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF ) , a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, is pleased to announce that its lead product candidate, Bria-IMT™, will be featured in a poster session on December 9 – 11 during the 2020 San Antonio Breast Cancer Symposium ® (SABCS), a virtual event. The po
October 6, 2020
· 3 min read